A 200-year history of Parkinson's disease

<p>In 1817, Dr. James Parkinson firstly described the concept, duration, and clinical characteristics of Parkinson's disease (PD). However, it was widely known until 1877 when it was named "Parkinson's disease" by Dr. Jean-Martin Charcot. In 1912, Frederic Henry Lewy, a...

Full description

Bibliographic Details
Main Authors: Xiao-dan WANG, Yong JI
Format: Article
Language:English
Published: Tianjin Huanhu Hospital 2017-01-01
Series:Chinese Journal of Contemporary Neurology and Neurosurgery
Subjects:
Online Access:http://www.cjcnn.org/index.php/cjcnn/article/view/1528
id doaj-ae0a646aa5ac4cfdb65f86b333e2b1cb
record_format Article
spelling doaj-ae0a646aa5ac4cfdb65f86b333e2b1cb2020-11-24T23:07:47ZengTianjin Huanhu HospitalChinese Journal of Contemporary Neurology and Neurosurgery1672-67312017-01-01171581497A 200-year history of Parkinson's diseaseXiao-dan WANG0Yong JI1Department of Neurology, Tianjin Huanhu Hospital, Tianjin 300350, ChinaDepartment of Neurology, Tianjin Huanhu Hospital, Tianjin 300350, China<p>In 1817, Dr. James Parkinson firstly described the concept, duration, and clinical characteristics of Parkinson's disease (PD). However, it was widely known until 1877 when it was named "Parkinson's disease" by Dr. Jean-Martin Charcot. In 1912, Frederic Henry Lewy, a neuropathologist, found a special abnormal protein in nerve cells of PD patients. Medical profession began to learn about the pathology of PD only when Konstantin Tretiakoff named the special abnormal protein "Lewy body (LB)" in 1919 and believed the main lesion of PD was in substantia nigra. In 1867, the German psychiatrist Leopold Ordenstein found that PD patients had symptoms of excitement of parasympathetic nerve, such as salivation, and treated them with belladonna alkaloids, thus creating a precedent for medical treatment of PD. After 1950's, the researchers gradually found that Lewy body was common in substantia nigra and locus coeruleus of PD patients and then gradually determined the pathological features of PD. The Swedish scientist Arvid Carlsson and Japanese neurologist Isamu Sano found dopamine abnormalities in the brain of PD patients, and thus researched and developed levodopa. PD has a history of 200 years, and we expect new research of PD studies.</p><p> </p><p><strong>DOI: </strong>10.3969/j.issn.1672-6731.2017.01.002</p>http://www.cjcnn.org/index.php/cjcnn/article/view/1528Parkinson diseaseHistory of medicineReview
collection DOAJ
language English
format Article
sources DOAJ
author Xiao-dan WANG
Yong JI
spellingShingle Xiao-dan WANG
Yong JI
A 200-year history of Parkinson's disease
Chinese Journal of Contemporary Neurology and Neurosurgery
Parkinson disease
History of medicine
Review
author_facet Xiao-dan WANG
Yong JI
author_sort Xiao-dan WANG
title A 200-year history of Parkinson's disease
title_short A 200-year history of Parkinson's disease
title_full A 200-year history of Parkinson's disease
title_fullStr A 200-year history of Parkinson's disease
title_full_unstemmed A 200-year history of Parkinson's disease
title_sort 200-year history of parkinson's disease
publisher Tianjin Huanhu Hospital
series Chinese Journal of Contemporary Neurology and Neurosurgery
issn 1672-6731
publishDate 2017-01-01
description <p>In 1817, Dr. James Parkinson firstly described the concept, duration, and clinical characteristics of Parkinson's disease (PD). However, it was widely known until 1877 when it was named "Parkinson's disease" by Dr. Jean-Martin Charcot. In 1912, Frederic Henry Lewy, a neuropathologist, found a special abnormal protein in nerve cells of PD patients. Medical profession began to learn about the pathology of PD only when Konstantin Tretiakoff named the special abnormal protein "Lewy body (LB)" in 1919 and believed the main lesion of PD was in substantia nigra. In 1867, the German psychiatrist Leopold Ordenstein found that PD patients had symptoms of excitement of parasympathetic nerve, such as salivation, and treated them with belladonna alkaloids, thus creating a precedent for medical treatment of PD. After 1950's, the researchers gradually found that Lewy body was common in substantia nigra and locus coeruleus of PD patients and then gradually determined the pathological features of PD. The Swedish scientist Arvid Carlsson and Japanese neurologist Isamu Sano found dopamine abnormalities in the brain of PD patients, and thus researched and developed levodopa. PD has a history of 200 years, and we expect new research of PD studies.</p><p> </p><p><strong>DOI: </strong>10.3969/j.issn.1672-6731.2017.01.002</p>
topic Parkinson disease
History of medicine
Review
url http://www.cjcnn.org/index.php/cjcnn/article/view/1528
work_keys_str_mv AT xiaodanwang a200yearhistoryofparkinsonsdisease
AT yongji a200yearhistoryofparkinsonsdisease
AT xiaodanwang 200yearhistoryofparkinsonsdisease
AT yongji 200yearhistoryofparkinsonsdisease
_version_ 1725617113098354688